Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Familial Cancer
|
March 23, 2011
Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
B E Kiely, M L Friedlander, R L Milne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2017
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
Y C Lee, R L Milne, S Lheureux, et al.
Familial Cancer
|
March 13, 2017
Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer
Y C Lee, M Bressel, P Grant, et al.
British Journal of Cancer
|
September 30, 2010
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
G S Dite, A S Whittemore, J A Knight, et al.
The Pharmacogenomics Journal
|
March 10, 2010
Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity
S Leskelä, C Jara, L J Leandro-García, et al.
Cancer Epidemiology
|
September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study
F J Bruinsma, S Jordan, J K Bassett, et al.
International Journal of Epidemiology
|
June 24, 2017
Cohort Profile: The Melbourne Collaborative Cohort Study (Health 2020)
R L Milne, A S Fletcher, R J MacInnis, et al.
International Journal of Obesity (2005)
|
December 27, 2017
Novel associations between blood DNA methylation and body mass index in middle-aged and older adults
Y M Geurts, P-A Dugué, J E Joo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium
A R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Familial Cancer
|
March 23, 2011
Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
B E Kiely, M L Friedlander, R L Milne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2017
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
Y C Lee, R L Milne, S Lheureux, et al.
Familial Cancer
|
March 13, 2017
Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer
Y C Lee, M Bressel, P Grant, et al.
British Journal of Cancer
|
September 30, 2010
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
G S Dite, A S Whittemore, J A Knight, et al.
The Pharmacogenomics Journal
|
March 10, 2010
Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity
S Leskelä, C Jara, L J Leandro-García, et al.
Cancer Epidemiology
|
September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study
F J Bruinsma, S Jordan, J K Bassett, et al.
International Journal of Epidemiology
|
June 24, 2017
Cohort Profile: The Melbourne Collaborative Cohort Study (Health 2020)
R L Milne, A S Fletcher, R J MacInnis, et al.
International Journal of Obesity (2005)
|
December 27, 2017
Novel associations between blood DNA methylation and body mass index in middle-aged and older adults
Y M Geurts, P-A Dugué, J E Joo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2019
Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium
A R Kreimer, A Ferreiro-Iglesias, M Nygard, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
Page
of 4